Malaria remains a leading cause of under�ve morbidity and mortality in sub-Saharan Africa. Effective case management is a strategy recommended by the World Health Organization for its control. A clinical audit of case management of uncomplicated malaria in under�ves in health facilities in Cross River State, Nigeria, was conducted from January to March 2012. Data was extracted from patients' case records by trained medical personnel using pretested data extraction forms. Of the 463 case records reviewed, age, gender, and weight were reported in 98.1%, 97.3%, and 49.7% of the children, respectively. A history of fever was obtained in 89.6% and a record of temperature in 74.1% of the children. General examination was performed in 203 (43.8%) children. Malaria parasite test was requested in 132 (28.5%) while Packed cell volume or haemoglobin was requested in 107 (23.1%) children. Appropriate dose of Artemisinin Combination erapy (ACT) was instituted in 300 (64.8%), wrong dose in 109 (23.5%), and inappropriate treatment in 41 (8.9%). e utilization of ACTs for treating uncomplicated malaria in the State has improved but clinical assessment of patients and laboratory con�rmation of diagnosis are suboptimum.
Background
Malaria remains a leading cause of childhood illness and death in sub-Saharan Africa with an under�ve annual mortality of approximately a million [1] . It is the most signi�cant public health problem in Nigeria where it accounts for 25% of under�ve mortality and 30% of childhood mortality. About 50% of the population will have at least one episode of malaria annually while about 24 million under�ves will have 2 to 4 attacks of malaria annually [2] .
Effective case management of uncomplicated malaria is a major strategy for malaria control. is entails proper clinical assessment, laboratory con�rmation of the disease either by light microscopy or rapid diagnostic technique (RDT) prior to treatment with an effective antimalarial [3] . Plasmodium falciparum (P. falciparum) is the most virulent of all the species that infect humans and accounts for over 95% of malaria-related morbidity and mortality in the country [4] . Chloroquine (CQ) and Sulfadoxine-pyrimethamine (SP) were used as �rst-and second-line treatment, respectively, for uncomplicated malaria until the emergence and intensi�cation of parasite resistance to these drugs which necessitated a review of the antimalarial treatment policy [5, 6] . e Nigerian government changed the treatment policy for uncomplicated malaria to the Artemisinin Combination erapy (ACT) in 2005 in keeping with the WHO recommendation. is was based on reports of a national antimalarial therapeutic efficacy study conducted the previous year in the different parts of the country that showed Artemether-lumefantrine and Artesunate-amodiaquine to be more efficacious than CQ or SP in treating uncomplicated P. falciparum malaria infection in under�ves [7] . e Nigerian government in partnership with some Non-Governmental Organizations has made signi�cant progress in scaling up the procurement and distribution of RDTs and ACTs to health facilities in the country [8] .
Most cases of malaria in the country are treated in private health facilities [9] . Effective case management of malaria in the private and public health facilities will not only reduce malaria-related under�ve morbidity and mortality but will also prevent the emergence of parasite resistance to the ACTs [3] . A systematic assessment of case management of malaria in health facilities in comparison with standard clinical guidelines is therefore necessary.
e �rst clinical audit of case management of uncomplicated malaria in the region was conducted in 2006 just aer the country officially transited from CQ or SP monotherapy to ACT as �rst-line treatment for uncomplicated malaria [10] . is was before the policy on laboratory con�rmation of diagnosis prior to treatment was introduced by WHO in 2010 [3] . Changes in treatment guidelines such as this further give credence to periodic clinical audit of case management of uncomplicated malaria in health facilities in comparison with national and international treatment guidelines.
is clinical audit aimed at determining the extent to which the case management of uncomplicated malaria in under�ves in Cross River State conforms to standard practice, identifying areas of shortfall and making recommendations to the Cross River State Ministry of Health on ways of improving the quality of care to under�ves being managed for uncomplicated malaria in health facilities in the State.
Methods

Design of the Study.
is was a clinical audit on treatment of uncomplicated malaria conducted on the medical records of health facilities in Cross River State, Nigeria, between January and March 2012.
2.2.
Setting of the Study. e audit was conducted on medical records of both public and private health facilities in Cross River State. In the public sector, both secondary and primary health facilities were assessed, while, in the private sector, private hospitals and clinics were assessed. Facilities located in both urban and rural areas were assessed. For the purpose of this audit, private hospitals/clinics were categorized as secondary health facilities.
Cross River State is one of the 36 political administrative states in the Federal Republic of Nigeria. Located in the south-eastern axis of the country within the tropical rain forest belt, the State has an annual rainfall of over 3500 millimetres. Malaria transmission is intense and perennial in this area.
Target Population
. e target population for the study was children aged less than �ve years receiving care at primary and secondary health facilities in Cross River State in the preceding 3-6 months. Only under�ves diagnosed and treated for uncomplicated malaria were included in this audit. ose above �ve years and under�ves treated for severe malaria or childhood illnesses other than uncomplicated malaria were excluded.
Sampling Methods.
Cross River State is comprised of three senatorial districts each made up of 6-7 Local Government Areas (LGAs). A LGA was selected in each senatorial district by simple random sampling. e public primary health facilities were selected by simple random sampling from a list of health facilities in the State obtained from the Cross River State Ministry of Health. Five primary facilities (primary health centres) and �ve secondary facilities (1 general hospital and 4 private hospitals) were selected per LGA. For private hospitals, there was no comprehensive list of health facilities across the State. us, outside Calabar metropolis, the �ve biggest private facilities were selected based on the assumption that more information will be obtained from them for the audit. Records of patients treated for malaria as diagnosed by the clinician 3-6 months prior to the study were audited.
e target was to audit �ve primary health facilities in each of the 3 selected LGAs. In each facility, a putative number of 15 case records of under�ves treated for uncomplicated malaria were randomly selected and audited. Likewise for each secondary (public and private) facility, we randomly selected and reviewed 15 records of under�ves treated for uncomplicated malaria per facility. is number of case records was considered adequate by the investigators to re�ect the current practice in the case management of malaria in under�ves in health facilities in the State.
Tool for Data Collection.
A clinical audit tool was developed from the monitoring and evaluation tools of the National Policy for Treatment of Malaria in Nigeria [11] . is tool was pretested and used to retrieve data from a sample of General Outpatient/Inpatient records of the selected facilities. Trained �eld workers (medical doctors, nurses, medical laboratory scientists, and community health officers) were responsible for extracting the data from hospital case record forms.
Ethical Issues. e proposal for the audit was reviewed and approved by the Cross River State Health Research Ethics
Committee. Consent to audit malaria treatment records of both the public and private hospitals/clinics was also sought and obtained from the Heads of those facilities. e con�dentiality of the patients' record and clinicians' identity were adequately protected using identi�cation numbers and codes for the patients and clinicians, respectively. e data extraction forms were archived in a cabinet under lock.
Data Extraction.
Information extracted from the records included patient's age, sex, weight, clinical features, diagnostic tests, and antimalarial drugs prescribed. e selected audit criteria in the data extraction form were checked as "�es, " "NO, " or "�nclear" based on �ndings. "Laboratory test ordered" was classi�ed when the attending clinician wrote down the tests to be done. "Laboratory tests done" was classi�ed when the results were recorded in the patient's record of the result sheets. e laboratory tests considered in this audit were those of malaria diagnosis (con�rmed either by light microscopy or RDT) and haematocrit (PCV) or haemoglobin (Hb) estimation. Children with PCV ≤ 21 g/dL were classi�ed as severely anaemic [12, 13] . Patients' age and weight were used to determine the appropriateness 
Clinical
Features of the Children. e history of fever was obtained in about 89.6%, while general examination was performed in 43.8% of the children. General examination was performed more frequently in the private facilities as shown in Table 2 .
Laboratory Investigations and Results of the Children.
Malaria test was requested for in 132 (28.5%) of the cases reviewed. Light microscopy was the main laboratory diagnostic method in 114 (86.4%). High level parasitaemia (+++/numerous) was recorded in 24 (5.3%) children, all of whom presented at the private facilities. Haemoglobin or PCV was requested in 107 (23.1%) of all children seen and was performed in 95 (88.8%) of them. Of the 95 children that had PCV estimation, 13 (13.7%) had severe anaemia all of whom presented at the private health facilities as shown in Table 3 .
Category of Treatment Obtained.
A total of 300 (64.8%) cases were treated with an Artemisinin-based Combination erapy (ACT). About 74% of children managed in the public facilities had an appropriate treatment regimen for uncomplicated malaria as against 42.2% in the private health facilities. Wrong dosage prescription was noted in 109 (23.5%). is was twice more likely in the private setting than in the public. e antimalarial prescription was inappropriate in 41 (8.9%) of the children treated in the facilities as shown in Table 4 .
e inappropriate drugs prescribed in the private health facilities were limited to Chloroquine (CQ) and Artesunate as monotherapy, while the public health facilities had a wide range of medications. CQ constituted 56.1% of the total inappropriate prescriptions. is was followed by Sulfadoxinepyrimethamine in 22.04% and inappropriate use of antibiotics in 9.8% of the cases.
Discussion
e �ndings of this practice audit show that the overall management of uncomplicated malaria in under�ves in these institutions are inconsistent with the recommendations of the treatment guidelines of the national malaria control programme and that of the World Health Organization [3, 14] . While age was well documented in most cases, records of the patients' weight were available for only 50% of the cases reviewed.
Since weight and age are required to determine the dose of the recommended �rst-line treatment for Artemetherlumefantrine and other ACTs, failing to record or use these parameters would invariably lead to the use of inappropriate dosage of these drugs. e current ACTs deployed in the country have predetermined doses matched for weight band and age range inscribed on the packets. is has simpli�ed the determination of correct dose of antimalarial and improved prescription pattern among health care providers in the absence of weight measurement. is is a laudable innovation given that a high proportion of children seen in health facilities in developing countries are oen not weighed before being treated as observed in this audit. In low-resource settings where instruments for measurements are unavailable, obtaining the necessary demographic information could be helpful in the decision-making process in patient management.
History of fever (89.6%) or temperature measurement (74.1%) was recorded in a higher proportion of patients than weight. ere is much room for improvement in this area since history of fever or measured axillary temperature ≥37.5 ∘ C is crucial for the de�nition of symptomatic malaria in children [3] . ere was a paucity of information on the symptoms of malaria in the case records of patients seen in both facilities. Some of the missing information may be among the de�ning criteria for severe malaria and could help to determine the presence or absence of concomitant infections. For example, pallor, enlarged liver, and spleen which are oen present in uncomplicated malaria were reported in relatively smaller proportion of patients. While hepatomegaly and splenomegaly may not have immediate diagnostic and prognostic signi�cance in uncomplicated malaria, the presence of either or both of these could prompt further investigations that may reveal such concurrent illness as sickle cell disorder or septicaemia [15, 16] . e low prevalence of these clinical signs in this study re�ects the failure of the clinicians to adequately examine the patients for them. Another Nigerian study reported that inadequate evaluation and underreporting of clinical �ndings were more common in the private than public health facilities [17] . e reverse is the case in the present study. Health providers in public health facilities tend to receive more training support from government agencies than their counterparts in private facilities and may be expected to adhere better to practice guidelines, but this does not appear to be the case in this audit [18] . It seems likely that a higher patient load in public health facilities makes such adherence difficult.
Most children were treated without parasitological con�rmation of diagnosis which is a practice that is now being discouraged. e Nigeria National Malaria Treatment Policy Guidelines has recently been revised making parasitological test con�rmation mandatory for diagnosis and treatment of malaria in all age groups [14] . e low rate of laboratory diagnosis of malaria in this study is similar to a report from a hospital-based clinical audit in a children's ward in Malawi [19] . e public health facilities were more likely to initiate treatment without laboratory con�rmation of diagnosis than the private facilities. It is worthy of note that a high proportion of the diagnosis was done using light microscopy with most patients having low grade parasitaemia. e use of RDTs was low despite the fact that this is currently being promoted as an acceptable alternative to microscopy where the latter is not available or feasible [3, 14] . is may indicate a short supply of the commodity in the facilities since its use does not require much technical expertise when compared with light microscopy. Six of the children managed in the private health facilities were reported to have had high parasite density. ese children could probably have been wrongly classi�ed as having uncomplicated malaria because hyperparasitaemia is one of the case-de�ning criteria for severe malaria with attendant increase in risk of mortality in under�ves [3] . Such misclassi�cation of severity of illness as may have been the case in this audit could lead to wrong treatment and poor outcome. Packed cell volume (PCV) or haemoglobin (Hb) was reported in less than a third of the cases reviewed. is was reported in one-third of the children managed in a health facility in Malawi [19] . e assessment of PCV or Hb in children being managed for malaria in the State is quite low. e high prevalence of P. falciparum infection in the country makes the under�ves vulnerable to rapid progression in disease severity and potentially fatal complications. Since anaemia is a common complication of malaria in endemic regions [12, 20] , it would be bene�cial to assess under�ves suspected of having malaria for anaemia by routinely measuring PCV or Hb.
Over 60% of the children had appropriate treatment regimen using an ACT. is �nding indicates a marked improvement in the utilization of ACTs for treating uncomplicated falciparum malaria when compared with 3% recorded in the State just aer the country formally transited from Chloroquine (CQ) or Sulfadoxine-pyrimethamine (SP) monotherapy to ACTs [10] . A similar increase in ACT utilization was observed in the Federal Capital Territory (FCT) of Nigeria where its prescription for treatment of uncomplicated malaria was as high as 81.4% [21] . is study, however, shows that a reasonable proportion of the doses of ACT prescribed were wrong. Wrong dosage of drugs was more common in the private health facilities than in the public health facilities. is could partly be due to the fact that most of the children in those facilities were not weighed before treatment was instituted. Wrong dosage of ACTs, especially subtherapeutic doses, will not only lead to treatment failure but could result in drug pressure and subsequent development of parasite resistance to the drugs. Indeed, reduced efficacy of artemisinins and ACTs has already been reported in some parts of Asia [22, 23] . Since the ACTs are currently the �rst-line treatment for uncomplicated malaria, effort needs to be made to prevent them from being wrongly prescribed. Prescription of subtherapeutic doses of CQ has shown to have contributed to the emergence and intensi�cation of parasite resistance to the drug [17] . Wrong or irrational ACT prescription should therefore be checked to prevent the development of parasite resistance to this useful drug.
About 9% of the children were treated with drugs that are inappropriate for uncomplicated malaria. is is also a remarkable improvement from earlier Nigeria studies that reported higher use of CQ and SP [24, 25] . CQ remains the leading inappropriate antimalarial used in the health facilities in the treatment of uncomplicated malaria. Further public enlightenment, training, and retraining of health providers on the national malaria treatment guideline would enhance rational use of antimalarial drugs among all cadres of health care workers.
Conclusions
e utilization of ACTs as a �rst-line therapy for uncomplicated malaria has signi�cantly improved. However, there is a need to improve clinical evaluation and laboratory con�rma-tion of malaria diagnosis in health facilities as recommended by the national and international malaria treatment guidelines. More efforts should be made to encourage and support health facilities to use RDTs for the diagnosis of malaria where light microscopy is not readily available or feasible.
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